NAVELLIER & ASSOCIATES INC - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 24 filers reported holding SINOVAC BIOTECH LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NAVELLIER & ASSOCIATES INC ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2023$014,6490.0%0.00%
Q2 2023$014,649
-2.7%
0.00%
Q1 2023$015,0560.0%0.00%
Q4 2022$015,056
+1.3%
0.00%
Q3 2022$014,867
-6.1%
0.00%
Q2 2022$015,8280.0%0.00%
Q1 2022$015,828
-28.6%
0.00%
Q4 2021$022,1780.0%0.00%
Q3 2021$022,178
-0.3%
0.00%
Q2 2021$022,2480.0%0.00%
Q1 2021$022,2480.0%0.00%
Q4 2020$022,248
-2.4%
0.00%
Q3 2020$022,786
-2.6%
0.00%
Q2 2020$023,387
-3.1%
0.00%
Q1 2020$0
-100.0%
24,141
-2.7%
0.00%
-100.0%
Q4 2019$161,00024,822
-8.7%
0.03%
Q3 2019$027,1900.0%0.00%
Q2 2019$027,1900.0%0.00%
Q1 2019$0
-100.0%
27,190
-6.1%
0.00%
-100.0%
Q4 2018$201,000
-14.1%
28,953
-5.9%
0.03%
+13.3%
Q3 2018$234,000
-1.7%
30,760
-3.5%
0.03%
-9.1%
Q2 2018$238,000
+70.0%
31,865
+28.5%
0.03%
+450.0%
Q2 2014$140,000
-21.8%
24,8000.0%0.01%
-25.0%
Q1 2014$179,000
+184.1%
24,800
+142.0%
0.01%
+166.7%
Q4 2013$63,00010,2500.00%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Verity Asset Management, Inc. 35,884$188,0000.17%
Orbimed Advisors 2,667,500$14,004,0000.10%
Freedom Investment Management, Inc. 157,295$826,0000.08%
Pine River Capital Management L.P. 1,095,041$5,749,0000.06%
FIRST MANHATTAN CO. LLC. 603,666$3,169,0000.02%
FIL Ltd 1,091,500$5,730,0000.02%
Renaissance Technologies 1,263,200$6,632,0000.02%
Zurcher Kantonalbank (Zurich Cantonalbank) 179,899$944,0000.01%
WELLINGTON MANAGEMENT GROUP LLP 4,068,406$21,359,0000.01%
ProShare Advisors LLC 44,592$234,0000.00%
View complete list of SINOVAC BIOTECH LTD shareholders